Use of atypical antipsychotics in neurodegenerative diseases

ISSN： 1479-6708

Source： Future Neurology, Vol.1, Iss.5, 2006-09, pp. : 553-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom

By Taylor David Mace Shubhra Mir Shameem Kerwin Robert

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 1, 2000-03 ,pp. : 41-46

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The production and use of cells as therapeutic agents in neurodegenerative diseases

By Isacson O.

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 417-424

Elsevier

Access to resources Recommend Favorite

Atypical antipsychotics in the elderly

By Beck Sarah Paton Carol Euba Rafael Goddard Cait

International Journal of Psychiatry in Clinical Practice, Vol. 5, Iss. 4, 2001-12 ,pp. : 257-261

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Atypicality of Atypical Antipsychotics Revisited

Current Psychiatry Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. : 316-324

Bentham Science Publishers

Access to resources Recommend Favorite

Patients' perceptions of their involvement in decision making about antipsychotic drug choice as outlined in the NICE guidance on the use of atypical antipsychotics in schizophrenia

By Paton Carol Esop Radia

Journal of Mental Health, Vol. 14, Iss. 3, 2005-06 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite